Physician profile
Peter P Herr
NPI 1801015250
$1,925.44
in general payments reported to CMS, 2019-2025
9 companies · $510 in 2025
The $510 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $339 · 2020: $227 · 2021: $170 · 2022: $226 · 2023: $56.12 · 2024: $396 · 2025: $510.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $962.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $962.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $1,212.18 | 2019-2025 | Collagenase Santyl, Regranex, Iodosorb Ointment 40g USA |
| Mimedx Group, INC. | $326.08 | 2024-2025 | |
| Organogenesis INC. | $113.17 | 2019-2023 | Puraply |
| Tactile Systems Technology INC | $82.75 | 2020-2025 | Flexitouch Plus, Entre Plus, Nimbl |
| Bioventus LLC | $60.68 | 2022-2025 | Exogen Ultrasound Bone Healing System |
| Surgenex LLC | $49.31 | 2025 | Surgraft, Ardeograft, Renograft |
| Kci USA, INC. | $46.17 | 2020 | |
| Pfizer INC. | $17.75 | 2019 | |
| Alfasigma USA, INC. | $17.35 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Peter Herr listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.